Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-07
DOI
10.1002/mc.22883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
- (2017) H Zhou et al. LEUKEMIA
- β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models
- (2017) Shanthi Ganesh et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Developmental Pathways: The Achilles Heel of Cancer?
- (2017) Wolfram C.M. Dempke et al. ONCOLOGY
- The role of GLI1 for 5-Fu resistance in colorectal cancer
- (2017) Lining Zhang et al. Cell and Bioscience
- HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
- (2017) Lei Sun et al. Journal of Cancer
- Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
- (2016) Wenju Chang et al. ANNALS OF SURGERY
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis
- (2016) L. Astudillo et al. CANCER RESEARCH
- Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance
- (2016) Salvador Alonso et al. JOURNAL OF CLINICAL INVESTIGATION
- SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer
- (2015) C. M. Della Corte et al. CLINICAL CANCER RESEARCH
- The Hippo pathway in colorectal cancer
- (2015) Piotr M. Wierzbicki et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Efficacy of Hedgehog Pathway Inhibitors in Basal Cell Carcinoma
- (2015) N. Basset-Seguin et al. MOLECULAR CANCER THERAPEUTICS
- Overcoming Resistance to Targeted Therapies in Cancer
- (2015) Keara L. Redmond et al. SEMINARS IN ONCOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
- (2014) Hiba Ahmad Zahreddine et al. NATURE
- Hedgehog Signaling Alters Reliance on EGF Receptor Signaling and Mediates Anti-EGFR Therapeutic Resistance in Head and Neck Cancer
- (2013) S. B. Keysar et al. CANCER RESEARCH
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- Hedgehog signaling from the primary cilium to the nucleus: an emerging picture of ciliary localization, trafficking and transduction
- (2013) Yoko Inès Nozawa et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10
- (2012) Laurence E. McCahill et al. JOURNAL OF CLINICAL ONCOLOGY
- Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
- (2012) A. D. Steg et al. MOLECULAR CANCER THERAPEUTICS
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
- (2009) L Yang et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started